August 26 Biotech Update

The market had a rough day yesterday where the rally from the “lows” earlier in the week faded at the end of the day. That is never a good sign.

August 25 Biotech Update

Despite ending the day down significantly, it actually felt like a good day. I wanted to post a real quick and short note as from now on Tuesday and Thursday.

August 24 Biotech Update

Wow. What a start to the week. In terms of news there was not much but we had an incredible flash crash in the large caps at the open. From.

August 21 Biotech Update

So it is obviously getting rough and we got our first peeks of panic yesterday. Most everyone seems to think that the worst is yet to come and I would.

August 20 Biotech Update

Another gap lower but the market remains in a rut refusing to breakdown or breakout. As I have said before, 2015 has been a year of churn and that is.

August 19 Biotech Update

Not much has changed sector wide since I last wrote but we did have a trade play out, although not quite the way I expected. I want to talk about.

August 14 Biotech Update

We had the continuation yesterday only to fail later in the day. It is looking that this bounce might only be setting up another leg lower but it is clearly.

August 13 Biotech Update

We had our reversal yesterday that I talked about, although I had my doubts for a little while. That is probably enough to get some buying interest barring additional negative.

August 12 Biotech Update

Essentially more of the same yesterday and into the morning today. At the very least, I think we are probably close to a bounce and would not be surprised to.

August 11 Biotech Update

Not a lot of biotech news again but macro is creeping back into the discussion with China devaluing their currency. Who knows the pin action this will have on the.

August 10 Biotech Update

We are getting a spurt of IO collaborations this morning but no major news or M&A. After the sell off Friday (and come back), I would not be surprised to.

August 7 Biotech Update

I am not able to write for a couple of days and the market goes to crap, I figured you all would be able to keep down the fort better.

August 4 Biotech Update

Looks like the sector was saving the fireworks for today with a lot more news. The reaction so far seems a little tepid given the positives but it is early.

August 3 Biotech Update

It is a pretty tame start to the week. I am a little surprised given that there seemed to be some bullish late Friday price and option action with concomitant.

July 31 Biotech Update

Not a lot of news so I want to round out a couple of issues this morning and close it out for the week. I am finding it more and.

July 30 Biotech Update

The sector is pretty weak, which is a continuation of the past couple of days. It is not immediately clear to me the reason for the weakness as earnings have.

July 29 Biotech Update

The sector was a strong performer after the bell but it did not seem to last long. The sector should be strong given the bulk of the earnings but I.

July 28 Biotech Update

The sector looked like it would be off to a good start but it faded quickly. I would still argue that any movement before the GILD earnings can be quickly.

July 27 Biotech Update

The market looks bad and it is bringing down the sector although I think BIIB has done a pretty good job at reversing some bullish biotech sentiment. That being said.

BioBlast Pharma: an under the radar ultra-rare disease company

  Bio Blast Pharma Ltd. (ORPN) – Nasdaq BioBlast Pharma (ORPN) is a clinical-stage biotech company, focused on treatments for rare and ultra-rare diseases, especially genetic and metabolic diseases. The company has three.

July 24 Biotech Update

Unlike earlier this week where bad news was shrugged off, it looks like we are going to see selling on the bad news. This pullback should eventually generate nice bargains.

July 23 Biotech Update

A good start to the day with earnings almost universally beats and raises. Given the strength the sector showed yesterday, this should move the group higher and increase expectations for.

July 22 Biotech Update

The sector is a little weak this morning, which is to be expected but not nearly as weak as I thought it would be going into the open. There has.

July 21 Biotech Update

The sector was green again yesterday and this morning but it does not seem to be a broad based move. The small caps appear to be underperforming and among the.

July 20 Biotech Update

There is some news this morning but nothing that in and of itself is likely to move the sector. On the other hand, the news has generally been positive, so.

July 17 Biotech Update

I leave town and the sector runs to new all-time highs and I come back and there is a pullback. Perhaps the market is trying to tell me something. It.

TRIL – Preparing For The Next Move Upward

  Trillium Therapeutics Inc. (TRIL) – Nasdaq Trillium (TRIL) is developing the next-generation of cancer immunotherapies. TRIL’s lead program, SIRPαFc, targets CD47 to prevent cancer cells from delivering a “do not eat”.

July 9 Biotech Update

It is a new day and apparently a new market with everything now OK. Clearly chop is the order of the summer (as is amnesia with the market having almost.

July 8 Biotech Update

We end one macro crisis and head directly into another. China, however, is more important than Greece so this makes a little more sense but even this selling is likely.

Catalyst Watch – Vol. 3, Edition 9 (7/8/15)

Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date published (or are noted),.

July 7 Biotech Update

There is a little more news today but still relatively quiet. The market seems to be looking for a direction but the sector seems to be outperforming to the upside..

Browsing 31 / 2 articles